Biotech | March 23, 2022
GMP certification for Exothera further extends its viral vector manufacturing capacity
The expansion makes Exothera one of the largest viral vector facilities in Europe
The expansion makes Exothera one of the largest viral vector facilities in Europe
Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
The facility will produce 150 million vaccine doses per year
The drug is indicated for use in combination with other drugs
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
Subscribe To Our Newsletter & Stay Updated
